|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
PACTR |
|
Last refreshed on:
|
29 May 2023 |
|
Main ID: |
PACTR201712002839259 |
|
Date of registration:
|
05/12/2017 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Perioperative heparinase rotational thromboelastometry monitoring in adult living related liver transplantation.
|
|
Scientific title:
|
Perioperative heparinase rotational thromboelastometry monitoring in adult living related liver transplantation. |
|
Date of first enrolment:
|
01/09/2015 |
|
Target sample size:
|
36 |
|
Recruitment status: |
Complete |
|
URL:
|
https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=2839 |
|
Study type:
|
Interventional |
|
Study design:
|
Parallel: different groups receive different interventions at same time during study,Randomised,Permuted block randomizaton. Block size 4,Sealed opaque envelopes
|
|
Phase:
|
Not Applicable
|
|
|
Countries of recruitment
|
|
Egypt
| | | | | | | |
|
Contacts
|
|
Name:
|
Elsayedamr
Basma |
|
Address:
|
30 Garden City Smouha
21615
Alexandria
Egypt |
|
Telephone:
|
00201223106023 |
|
Email:
|
elsayedamr@yahoo.com |
|
Affiliation:
|
Patient Information Manager |
|
|
Name:
|
Ahmed
Metwally |
|
Address:
|
Hussin Abd Alghafaar st
32512
Shbeen Elkoom
Egypt |
|
Telephone:
|
002-01100085450 |
|
Email:
|
drahmedabdelraouf@yahoo.com |
|
Affiliation:
|
Professor of Anaesthesia and Intensive Care |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: All adult patients with end stage liver disease scheduled for live adult liver transplantation were enrolled within a 2 year study period.
Exclusion criteria: Any factor that interfere with coagulation such as patient on oral anticoagulant, or on procoagulant as activated factor seven (Novoseven).
Age minimum:
30 Year(s)
Age maximum:
65 Year(s)
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Digestive System
|
Digestive System
End-stage liver disease for scheduled liver transplantation
|
|
End-stage liver disease for scheduled liver transplantation
|
|
Intervention(s)
|
|
|
|
Hypercoagulable
|
|
Non Hypercoagulable
|
|
Primary Outcome(s)
|
|
Clotting Time (CT) of heparinase ROTAM
|
|
Maximal Clot Firmness (MCF) of heparinase ROTAM
|
|
Secondary Outcome(s)
|
|
Post-operative heparin infusion effect on ROTAM and standard coagulation tests
|
|
Source(s) of Monetary Support
|
|
Faculty Medicine, of Menoufia University
|
|
Ethics review
|
Status: Approved
Approval date: 05/09/2015
Contact:
National Liver Institute IRB
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|